Tramadol Hcl Tablet, Extended Release
Product Images NDC 80425-0141

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tramadol Hcl (NDC 80425-0141). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Pharmacy Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig 1

A line graph comparing Tramadol plasma concentration over 24 hours for Tramadol Hydrochloride Extended-Release Tablets 200 mg once daily versus Tramadol Immediate-Release Tablets 50 mg every 6 hours, showing concentration (ng/mL) on the y-axis and time (hours) on the x-axis.*

FDA Label Image

Fig 2

A line graph comparing M1 concentration (ng/mL) over 24 hours for Tramadol Hydrochloride Extended-Release Tablets (200 mg once daily) and Tramadol IR Tablets (50 mg every 6 hours). The x-axis represents time in hours, and the y-axis shows M1 concentration in ng/mL.*

FDA Label Image

Fig 3

A line graph titled 'Tramadol Hydrochloride Extended-Release Tablets Study 023 WOMAC Pain Responder Analysis' showing the percent of patients achieving various levels of response threshold based on percent improvement from baseline. The graph compares extended-release tablets of Tramadol Hydrochloride at 100 mg, 200 mg, 300 mg, and 400 mg doses, alongside a placebo, across response thresholds from 0 to 100 percent.*

FDA Label Image

Fig 4

A line graph comparing the percent of patients achieving response between Tramadol Hydrochloride Extended-Release Tablets and placebo. The x-axis represents response threshold as percent improvement from baseline, ranging from 0 to 100, and the y-axis shows the percent of patients achieving response, from 0 to 60 percent. The graph depicts higher response rates for Tramadol compared to placebo across various thresholds.*

FDA Label Image

Structure

Chemical structure of Tramadol HCL, depicting the molecular arrangement including the cyclohexane ring, methoxyphenyl group, hydroxyl group, dimethylamino group, and hydrochloride component.*

FDA Label Image

Tramadol HCl Er 100mg Qty 30 Ndc 80425 0141

Label for Tramadol HCL ER 100 mg extended-release tablets, bottle of 30, labeled by Advanced Rx Pharmacy of Tennessee, LLC in Nashville, TN. The label includes the product NDC 80425-0141-01 and lot number 30TR100223, with a source NDC 47353-0859-83 and expiration date 2/8/2023. Storage instructions specify keeping the product at controlled room temperature (20°-25°C).*

FDA Label Image

Tramadol HCl Er 100mg Qty 60 Ndc 80425 0141

Label for Tramadol HCL 100 mg extended-release tablets by Advanced Rx Pharmacy of Tennessee, LLC. The label includes dosing comparison to Ultram ER, the NDC number 80425-0141-02, lot number 60TR100223, bar code, and storage instructions (20°-25°C). It is marked for a 60-tablet package and indicates the source and manufacturer details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.